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Abstract
Background: In resource-poor settings, transfused children often experience recurrence of severe anemia (SA)
following discharge from hospital. This study determined the factors associated with recurrent severe anemia (RSA)
among previously transfused Ugandan children aged less than 5 years.
Methods: A case-control study was conducted in five hospitals in Uganda from March 2017 to September 2018.
We prospectively enrolled 196 hospitalised children who had been transfused for severe anemia 2 weeks to 6
months prior to enrollment. Of these, 101 children (cases) were re-admitted with a hemoglobin [Hb] level of ≤6 g/
dL and required transfusion; and 95 children (age-matched controls) were admitted for other clinical illness with a
Hb > 6 g/dL. Children known to have sickle cell anemia, cancer, or bleeding disorders were excluded. Clinical and
laboratory evaluation were done. Conditional logistic regression adjusted for age, was used to determine factors
associated with RSA.
Results: The median time (IQR) between the earlier transfusion and enrollment was 3.5 (1.9–5.7) months for cases,
and was 5.0 (2.9–6.0) months for controls (p-value = 0.015). Risk factors (adjusted odds ratio, 95% confidence interval,
and significance) for development of RSA were: hemoglobinuria (36.33, 2.19–600.66, p = 0.012); sickle cell anemia –
newly diagnosed (20.26, 2.33–176.37, p = 0.006); history of earlier previous transfusions (6.95, 1.36–35.61, p = 0.020) and
malaria infection (6.47, 1.17–35.70, p = 0.032).
Conclusion: Malaria chemoprevention, follow up visit for Hb check after discharge from hospital and sickle cell screening
among previously transfused children represent practical strategies to prevent and identify children at risk for recurrent
severe anemia. The cause of hemoglobinuria in children merits further investigations.
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Background
Recent studies have indicated that up to 10% of children
who receive blood transfusion for severe anemia (SA)
return to health facilities with recurrence of severe anemia
within three months of discharge, while others die at home
[1]. Moreover, children with recurrent severe anemia (RSA)
are 10 times more likely to die compared to their non-
anemic counterparts during the post-discharge period [1].
However, the risk factors associated with recurrent severe
anemia among previously transfused children have not
been sufficiently studied.
Malaria infection in the immediate post-discharge period
has been identified to be a major contributing factor to
RSA in children [2]. Other documented risk factors include;
poor socio-economic status, large family size, history of
recurrent transfusions and human immuno-deficiency virus
(HIV) infection [1]. Recurrent life-threatening anemia in
children in sub-Saharan Africa may have several underlying
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mechanisms. From a pathophysiological view point, the
relative roles of insufficient erythroid production and
increased red cell destruction have not been fully defined
[3, 4].
A better understanding of the risk factors for develop-
ment of RSA can identify children at highest risk and
can enhance the benefits of blood transfusion in children
[5, 6]. We conducted an age-matched case-control study
to determine the factors associated with recurrent severe
anemia among previously transfused Ugandan children
aged less than 5 years.
Methods
Study design
This was an age-matched study with a ratio of 1:1 be-
tween cases and controls.
Study setting
The study was conducted at Jinja, Masaka, Hoima,
Mubende and Kamuli hospitals, in Uganda. The first four
are all public regional referral hospitals serving east-central,
south-central, north-central, and western sub-regions of
Uganda respectively, while Kamuli mission hospital is a pri-
vate not-for-profit hospital located in eastern Uganda. Each
of the hospitals has a pediatric ward with an in-patient bed
capacity ranging from 30 to 80.
Study population, inclusion and exclusion
We enrolled children aged 2months to 5 years with prior
severe anemia (cases and controls) that required a blood
transfusion, which was given > 2weeks but < 6months
prior to enrollment in the present study. Cases were
defined as children who at the time of study enrollment
were re-admitted to the hospital with a hemoglobin level of
≤6 g/dL and required blood transfusion. Controls were de-
fined as children who at the time of study enrollment were
being seen for other clinical illness as an inpatient or out-
patient, and had a hemoglobin level of > 6 g/dL. Cases and
controls were matched using an age range of ±12months.
Children known to have sickle cell anemia (SCA), cancer,
bleeding disorders or whose anemia was caused by trauma,
were excluded.
Sample size and sampling
The sample size of 196 was estimated using Open EPI
calculator; using malaria as the main risk factor with a
prevalence of 29.3% among cases and 12.1% among
controls, according to a study by Phiri KS et al 2008 [1],
and considering a two-sided confidence level of 95%, an
acceptable type 1 error of 5% and power of 80%. A study
clinician evaluated all prospective participants for eligibility
at each study site and eligible participants were enrolled
consecutively.
Study variables and data collection
Clinical evaluations included the past medical history (in-
cluding the number of previous transfusions, past hospitali-
zations and diagnosis during these hospitalizations), socio-
family history and a detailed physical examination and an-
thropometric measurements (weight, height and mid-upper
arm circumference [MUAC]). Socio-demographic data
collected included; sex, age in months, age and occupation
of caregiver, number of household members, number of
children in the household, number of meals per day, among
others. A structured case-report form was used to record
study variables.
Laboratory measurements
A blood sample of 2ml collected in an EDTA tube was
taken (for cases - taken off at pre-transfusion). Hemoglobin
was measured using a point-of-care device (Hemocue® 201,
Angelholm, Sweden). ABO typing and Rhesus blood
grouping was done using commercial reagents available at
the hospital blood banks. Complete blood count (FBC)
tests were performed using the Mindray automated
haematology analyzer (Shenzhen Mindray Bio-Medical
electronics Co. Ltd., Shenzhen, China). Sickle cell status
(either Hb-AA, AS or SS) was determined by capillary
hemoglobin electrophoresis assay (Sebia minicap, Evry-
France). For patients returning within two months since
previous transfusion, hemoglobin electrophoresis was
deferred for at least two months. HIV serology was tested
using HIV-1/2 test strips (Alere Medical Co. Ltd., Chiba,
Japan). Urine analysis was done using URS-10 T reagent
test strips (Zhejiang Orient Gene Biotech Co. Ltd.,
Zhejiang, China). Malaria thick-smear was stained using
field stain A and B. Malaria rapid diagnostic test (RDT)
was done using SD Bio-line malaria Ag P.f/Pan test strips
(SD Standard diagnostics, INC, Alere Co., Korea). A reticu-
locyte count (%) was performed from a fresh (within 2 h)
sample, using a thin smear stained with new methylene
blue, and the reticulocyte production index – RPI (corrects
for the degree of anemia) was calculated using the method
of Poorana et al [7]. Some tests such as Hb-electrophoresis
and reticulocyte count could not be performed among
some urgent cases who presented in the night and for
whom a pre-transfusion study sample was not obtained.
The presence of asexual forms of plasmodium species on
a thick malaria smear or a positive malaria RDT defined
the diagnosis of malaria, while hemoglobinuria was defined
by both a history of passage of dark or red-colored urine,
and confirmed evidence of ‘blood’ at urine dip-stick. Sickle
cell anemia and sickle cell trait were defined as the presence
of Hb-SS and Hb-AS, respectively. Suspected bacteremia
was a clinical diagnosis backed by laboratory evidence neu-
trophilia on FBC. Mean cell volume (MCV) < 70 fL defined
microcytosis, while MUAC of ≤12.5 cm defined malnutri-
tion (severe acute, and moderate acute malnutrition) [8].
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Data management and statistical analysis
Data were entered into EPI-DATA version 3.1 software
package (The EpiData Association, Odense, Denmark) and
analysed using STATA v14.0 (Stata, College Station, TX,
USA). We computed descriptive statistics and present,
medians (interquartile range), proportions for the demo-
graphic characteristics by case or control status. Associ-
ation between categorical variables was assessed using odds
ratios and statistical significance determined using the
McNemar test. Means of symmetrical continuous variables
were compared using the paired t-test. The difference in
median time from earlier transfusion to enrollment was
evaluated with a Wilcoxon rank sum test. 95% test-based
confidence intervals for odds ratios and p-values are
presented from conditional logistic regression adjusted for
children’s age as matching variable. The stepwise backward
model building technique was followed to identify signifi-
cant factors after adjusting for factors with p values < 0.2
for consideration into the multivariable model. A p < 0.05
was considered statistically significance. All p-values
presented are two sided.
Results
A total of 101 cases and 95 age-matched controls enrolled
in the study were included in the analysis. Kamuli study site
had slightly more cases than controls (Table 1). The base-
line characteristics of cases and controls were comparible
except for the median time (IQR) from prior transfusion to
enrollment which was 3.5 (1.9–5.7) and 5.0 (2.9–6.0)
months among cases and controls respectively (p-value =
0.015) .
Matched bivariable analysis
The factors that were independently associated with RSA
are summaried in Table 2. History of earlier previous
blood transfusions (in the period > 6months), history of
other previous admissions, passage of dark or red-colored
urine and Artemisinin-based combined therapy (ACTs)
use prior to admission on the current illness were signifi-
cantly associated with recurrence of SA. A diagnosis of
malarial anemia at the most recent previous admission,
diagnosis of malaria at the current admission, SCA, and
hemoglobinuria were independently associated with RSA.
In contrast, socio-economic factors such as occupation
of the caregiver, highest education level of the mother,
number of children in the household, number of meals
per day among others, were not associated with RSA.
Other diagnoses such as severe pneumonia, diarrhea,
and urinary tract infections were infrequent. Only one
participant (a control) was HIV infected.
Multivariable analysis
All variables with a p-value < 0.2 at bivariable analysis
(hemoglobinuria, sickle cell anemia, history of earlier previ-
ous blood transfusions [in the period > 6months], passage
of dark or red-colored urine, malaria diagnosis at current
Table 1 Baseline characteristics of study participants
Variable Study category
Total (n = 196) Cases (n = 101) Controls (n = 95)
Age of child in months (matching criterion), mean (SD)* 31.3 (14.4) 32.2 (14.3) 30.3 (14.5)
Sex, n (%)
Female 81 (41.3) 43 (42.6) 38 (40.0)
Male 115 (58.7) 58 (57.4) 57 (60.0)
Mother’s age in years, mean (SD) 28.4 (6.3) 28.5 (6.4) 28.3 (6.2)
Study site, n (%)
Jinja 116 (59.2) 58 (57.4) 58 (61.1)
Masaka 34 (17.4) 16 (15.8) 18 (18.9)
Hoima 25 (12.8) 12 (11.9) 13 (13.7)
Kamuli 15 (7.6) 12 (11.9) 3 (3.2)
Mubende 6 (3.1) 3 (2.9) 3 (3.2)
Caregiver relationship to the child, n (%)
Mother 130 (66.3) 67 (66.3) 63 (66.3)
Father 47 (23.9) 26 (25.7) 21 (22.1)
Others (Grand, Auntie, etc) 19 (9.7) 8 (7.9) 11 (11.6)
Occupation of caregiver, n (%)
Employed 48 (24.5) 25 (24.8) 23 (24.2)
Un-employed 148 (75.5) 76 (75.2) 72 (75.8)
*SD = standard deviation
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Table 2 Bivariable associations with recurrent severe anemia
Variable Study category
Cases N = 101 Controls N = 95 *Crude odds ratio (95% CI) p-value
Socio-demographics
Age in months, mean (SD) 32.2 (14.3) 30.3 (14.5)
Sex, n (%)
Female 38 (40.0) 43 (42.6) 1.00
Male 57 (60.0) 58 (57.4) 0.92 (0.45,1.85) 0.805
Occupation of caregiver, n (%)
Un-employed 76 (75.2) 72 (75.8) 1.00
Employed 25 (24.8) 23 (24.2) 0.94 (0.43,2.04) 0.879
Highest education level of mother, n (%)
None and primary 78 (77.2) 66 (69.5) 1.00
Secondary and above 23 (22.8) 29 (30.5) 0.88 (0.42,1.84) 0.727
Mother’s age, n (%)
≤ 28 years 51 (56.0) 46 (54.8) 1.00
≥ 29 years 40 (44.0) 38 (45.2) 0.58 (0.66,1.27) 0.173
No. of children in household, n (%)
≤ 2 24 (23.8) 22 (23.2) 1.00
≥ 3 77 (76.2) 73 (76.8) 0.90 (0.40,2.01) 0.802
Total no. of people in household, n (%)
≤ 7 61 (60.4) 64 (67.4) 1.00
≥ 8 40 (39.6) 31 (32.6) 1.05 (0.52,2.11) 0.895
No. of meals per day, n (%)
≤ 2 25 (41.7) 29 (67.4) 1.00
≥ 3 35 (58.3) 14 (32.6) 1.73 (0.67,4.50) 0.258
History
Passage of dark or red-colored urine, n (%)
No 61 (60.4) 90 (94.7) 1.00
Yes 40 (39.4) 5 (5.3) 14.7 (3.34,64.80) < 0.001
ACTs use prior to admission, n (%)
No 66 (65.5) 79 (83.2) 1.00
Yes 35 (34.7) 16 (16.8) 2.67 (1.21,5.91) 0.015
Malarial anemia at most recent admission
No 25 (25.0) 18 (18.9) 1.00
Yes 75 (75.0) 77 (81.1) 0.39 (0.15,0.98) 0.044
History of other previous admissions
No 36 (35.6) 59 (62.1) 1.00
Yes 65 (64.4) 36 (37.9) 2.96 (1.59,5.52) < 0.001
History of earlier previous transfusions
No 52 (51.5) 78 (82.1) 1.00
Yes 49 (48.5) 17 (17.9) 4.32 (2.15,8.82) < 0.001
At current admission
Malaria diagnosis
No 33 (32.7) 45 (47.4) 1.00
Yes 68 (67.3) 50 (52.6) 2.19 (1.08,4.45) 0.030
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admission, mother’s age, ACTs use prior to admission, mal-
arial anemia at most recent admission, history of other pre-
vious admissions, and suspected bacteremia) were entered
into a stepwise backward conditional logistic regression
model. After controlling for all ten variables, we found that
hemoglobinuria, sickle cell anemia (Hb-SS), history of earl-
ier previous blood transfusions (in the period > 6months),
and malaria diagnosis were each significantly associated
with RSA (Table 3).
Relationship between hemoglobinuria and sex
There were 10 (23.3%) cases and 1 (2.6%) control female
participants compared to 28 (48.3%) cases and 4 (6.9%)
control male participants with hemoglobinuria respectively.
However at logistic regression, the interaction between
hemoglobinuria and sex was not statistically significant.
The odds of a participant with hemoglobinuria being male
were; AOR = 1.27(95% CI: 0.09–16.88, p-value =0.855) that
of females.
Discussion
This study set out to determine the factors associated with
recurrent severe anemia among previously transfused
Ugandan children aged < 5 years re-admitted to hospital.
The results of this study suggest that hemoglobinuria, sickle
cell anemia, a history of earlier previous transfusions (in the
period > 6 months) and malaria are risk factors for recur-
rent severe anemia. In addition, history of other previous
admissions, and Artemisinin-based combined therapy
(ACTs) use prior to admission on the current illness are
independently associated with RSA. In contrast, mother’s
age ≥ 29 years and a diagnosis of malarial anemia at the
most recent admission seem protective. These findings are
comparible to the findings of Phiri KS et al 2008 and
Lackritz EM et al 1997 with regard to malaria and history
of earlier previous transfusions [1, 2].
It is worth noting that 75.0% of cases had a diagnosis
of malarial anemia at the most recent prior admission
– in the immediate past six months, before returning
with RSA. This underscores the role of malaria in the
etiology of severe anemia among children in malaria
endemic areas [9]. Although children known or sus-
pected to have SCA were excluded at enrolment, we
found 15 children with sickle cell anemia. These had
not been diagnosed before. Indeed, in such settings as
this with a documented prevalence of sickle cell gene as
Table 2 Bivariable associations with recurrent severe anemia (Continued)
Variable Study category
Cases N = 101 Controls N = 95 *Crude odds ratio (95% CI) p-value
Suspected bacteremia diagnosis
No 55 (54.5) 67 (70.5) 1.00
Yes 46 (45.5) 28 (29.5) 1.93 (0.97,3.84) 0.060
Hemoglobinuria diagnosis
No 63 (62.4) 90 (94.6) 1.00
Yes 38 (37.6) 5 (5.3) 12.18 (3.40,43.65) < 0.001
ǂ Sickle cell status, newly diagnosed
Normal (Hb-AA) 47 (73.4) 42 (84) 1.00
Sickle cell trait (Hb-AS) 8 (12.5) 2 (4) 1.44 (0.24,8.71) 0.692
Sickle cell anemia (Hb-SS) 9 (14.1) 6 (12.0) 4.21 (1.03,17.13) 0.045
Reticulocyte production index
> 2 20 (37.7) 14 (37.8) 1.00
≤ 2 33 (62.3) 23 (62.2) 1.40 (0.37,5.22) 0.621
MUAC, n (%)
≤ 12.5 cm 9 (9.1) 5 (5.3) 1.00
> 12.6 cm 90 (90.9) 89 (94.7) 0.41 (0.10,1.73) 0.223
ABO blood grouping
Group O 36 (50.0) 28 (50.0) 1.00
†Non- group O 36 (50.0) 28 (50.0) 1.02 (0.41,2.57) 0.963
MCV¶
> 70 fl 41 (100) 36 (94.7)
≤ 70 fl 0 (0) 2 (5.3)
* OR by McNemar method, ǂ114 samples tested, †Group A = 28, B = 30, AB = 6 among 128 tested, no stat test done here
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high as 17% [10, 11], children presenting with SA
deserve to be evaluated for SCA.
This study has found hemoglobinuria (defined by history
of passage of dark or red-colored urine and the presence of
blood at urine dip-stick) to be associated with RSA. This
syndrome whose cause is not well understood has recently
been documented to be common in the eastern region of
Uganda. The syndrome has been associated with SA and
positive malaria RDT (despite having negative malaria
smears) but not with sickle cell disease or G6PD-de
ficiency [12]. Although G6PD-deficiency, a sex-linked
disorder has been documented to be associated with
hemoglobinuria, the study by Olopot-Olupot P et al did
not find this to be so.
Similarly, in our case-control although we did not per-
form G6PD assays, we found that the odds of a participant
with hemoglobinuria being male were not statistically
significant.
The potential relationship between hemoglobinuria and
prior use of ACTs and/or other genetic factors in the
causation of RSA need to be confirmed. Other reports
have shown the possible role of ACTs-related delayed
hemolytic anemia in causing RSA [13].
Although the reticulocyte production index was not
statistically lower among cases, the potential role of
insufficient erythrocyte production predisposing to RSA
cannot be excluded for reasons of the fewer numbers we
tested. What also remains unknown is how malarial
anemia at the most recent admission may be protective
against RSA, yet malaria itself is implicated in causing
both SA and RSA. This paradoxical finding has also
been reported by Phiri KS et al 2008.
Nutritional status as measured by the MUAC and
socio-economic factors such as occupation of caregiver,
highest education level of mother, number of children in
the household, number of meals per day, among others
were not associated with recurrent severe anemia. Al-
though this study did not have power to evaluate them,
there is evidence to suggest that these factors among
others may play a significant role in causing both SA
and RSA [1, 14]. Contrary to the findings of Phiri KS et
al where HIV infection was associated with RSA, we
found only one participant – a control to be HIV posi-
tive. This may be explained by the marked progress
made with regard to elimination of mother to child
transmission of HIV in Uganda [15].
In summary, recurrent severe anemia among previ-
ously transfused children in Uganda occurs after about
three months, and is related to hemoglobinuria, sickle
cell anemia, history of earlier previous transfusions and
malaria infections and/or re-infection.
Limitation
The current list of factors associated with RSA may not
be complete. One uncertainty may be the role of socio-
demographic factors such as occupation of caregiver,
number of household members, number of meals
among others that our study did not have power to
evaluate. Similarly, the fewer numbers tested for vari-
ables such as reticulocyte production index further
limits the power.
Conclusions
Evidence based interventions are needed to prevent and
mitigate the problem of recurrent severe anemia among
children. The post-discharge malaria chemoprevention
trial (NCT02671175) is currently testing the hypothesis
that malaria is a key factor in the cause of post-discharge
mortality and morbidity in children with severe anemia.
Table 3 Multivariable results for factors associated with recurrent severe anemia
Variable Crude odds ratio (95% CI) p-value Adjusted odds ratio (95% CI) p-value
History of earlier previous transfusion
No 1.00
Yes 4.32 (2.15,8.82) < 0.001 6.95 (1.36,35.61) 0.020
Hemoglobinuria at admission
No 1.00
Yes 12.18 (3.40,43.65) < 0.001 36.33 (2.19,600.66) 0.012
Sickle cell status
Normal (Hb-AA) 1.00
Sickle cell trait (Hb-AS) 1.44 (0.24,8.71) 0.692 16.10 (0.06,4766.8) 0.325
Sickle cell anemia (Hb-SS) 4.21 (1.03,17.13) 0.045 20.26 (2.33,176.37) 0.006
Malaria diagnosis at admission
No 1.00
Yes 2.19 (1.08,4.45) 0.030 6.47 (1.17,35.70) 0.032
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The results of that trial are eagerly awaited. However,
there is need to address the other risk factors for RSA;
such as screening for SCA among all children with SA
and a follow up visit between 2 weeks and 3months for
Hb check after discharge from hospital (the best timing
for this check remains yet to be determined). Generally,
the problem of recurrent severe anemia among children
merits further investigation, including areas such as the
cause of hemoglobinuria and its potential relationship
with prior ACTs use.
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